Find prior art in drug patents and published literature Let DrugPatentWatch help with your patent due diligence Our deep analysis can help you quickly access the information you need to…
The post DrugPatentWatch Prior Art Reports appeared first on Drug…
Information contained in expired drug patents can be invaluable to researchers developing new products, but caution is required to avoid legal problems.
The post How Companies Can Extract Value from Expired Drug Patents appeared first on DrugPatentWatc…
According to the Louisiana Department of Health, an estimated 500 people per year are infected with hepatitis C (HCV) in Louisiana. By 2016, the number of identified HCV cases in that state…
The post A ‘Netflix’ Model for Drug Pricing to Bring Treatmen…
Successful drug patent challengers get 180 days of market protection The Food and Drug Administration rewards successful drug patent challengers by giving them 180 days of generic market exclusivity (see…
The post Day 181 Generic Drug Launch – A Fast a…
This article was originally published by Kiu Tay-Teo, PhD, André Ilbawi, MD, and Suzanne R. Hill, PhD in JAMA Netw Open. 2019;2(1):e186875. under the terms of the CC-BY License. Key Points Question How does income from…
The post Comparison of Sales In…
Recent successful drug launches indicate a trend toward more specialized, high-priced drugs that treat less-common medical conditions.
The post Conclusions We Can Draw from Recent Successful Drug Launches appeared first on DrugPatentWatch – Make Better…
Pharmaceutical formulary managers have a pressing need to manage their formulary budgets. Anticipating when drugs will face loss-of-exclusivity — when their key patents will expire — is an essential first-step…
The post Pharmaceutical Formulary Managem…
This paper was originally published by Jian Du, Peixin Li, Qianying Guo, and Xiaoli Tang at Journal of Informetrics Volume 13, Issue 1, February 2019, Pages 132-148 under a a Creative Commons license.…
The post Measuring the knowledge translation and c…
Prescription drugs are expensive to develop, and many intermediaries stand between patients and drug makers. Here’s where the money goes.
The post Drug Spending in the US: Where the Money Actually Goes appeared first on DrugPatentWatch – Make Better De…
Businessman and investor Mark Cuban is probably best known as the owner of the Dallas Mavericks and as an investor on the reality television series Shark Tank. His business and…
The post Mark Cuban Unexpected Leader in Orphan Drug Development Reform ap…